Endava is trading at $2.00, down 5.18%, as investors continued selling following the September 21, 2026 disclosure that CFO Mark Thurston was placed on administrative leave during an independent accounting investigation.
- The review concerns accounting treatment for certain customer and supplier agreements; Conor McShane was appointed interim CFO.
- Broader U.S. equity weakness is adding pressure, though governance and reporting concerns appear to be the primary catalyst.